LONG-TERM SURVIVAL IN PATIENTS TREATED FOR TESTICULAR SEMINOMA

被引：6

作者：

HANNUN, Y

VUGRIN, D

机构：

[1] TEXAS TECH UNIV,HLTH SCI CTR,DIV ONCOL,LUBBOCK,TX 79430

[2] DUKE UNIV,MED CTR,DIV HEMATOL & ONCOL,DURHAM,NC 27710

来源：

JOURNAL OF SURGICAL ONCOLOGY | 1990年 / 43卷 / 03期

关键词：

chemotherapy; cure rates; surgery;

D O I：

10.1002/jso.2930430311

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Forty‐eight patients with newly‐diagnosed testicular seminomas were followed for a mean of 7 years after treatment. At the time of diagnosis, seminoma was confined to testis in 74% (36) and was metastatic to retroperitoneal lymph nodes in 15% (7) and to distant nodal sites or parenchymal organs in 10% (5). Ninety‐six percent remained free of disease, 94% in first complete remission (CR) and 2% after treatment of first recurrence. Long‐term disease‐free survival in CR per stage was 97% (35/36) for Stage I, 100% for Stage II, and 80% (4/5) for Stage III. However, three patients, who received prior chest radiation therapy (RT), died from acute myocardial infarction 2, 9, and 10 years after treatment and while free of disease. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company

引用

页码：177 / 180

页数：4

共 11 条

[1]

BALL D, 1982, CANCER, V50, P2289, DOI 10.1002/1097-0142(19821201)50:11<2289::AID-CNCR2820501112>3.0.CO

[2]

2-X

[3]

MOSTOFI FK, 1973, ATLAS TUMOR PATHOL 2

[4]

SMITH RB, 1978, GENITOURINARY CANCER, P460

[5]

THOMAS GM, 1985, CANCER, V55, P2296, DOI 10.1002/1097-0142(19850501)55:9+<2296::AID-CNCR2820551438>3.0.CO

[6]

2-V

[7]

VANOOSTEROM AT, 1985, GERM CELL TUMORS, V2, P229

[8]

VUGRIN D, 1984, CANCER, V53, P2422, DOI 10.1002/1097-0142(19840601)53:11<2422::AID-CNCR2820531110>3.0.CO

[9]

2-2

[10]

VUGRIN D, 1981, CANCER, V47, P833, DOI 10.1002/1097-0142(19810301)47:5<833::AID-CNCR2820470502>3.0.CO

← 1 2 →